If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 340.60
Bid: 340.40
Ask: 340.80
Change: 2.40 (0.71%)
Spread: 0.40 (0.118%)
Open: 339.60
High: 342.20
Low: 337.00
Prev. Close: 338.20
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

25 Nov 2020 07:00

RNS Number : 3913G
Rotork PLC
25 November 2020
 

25 November 2020

Rotork Plc

Trading update

Improved resilience demonstrated and guidance reinstated

Rotork plc ("Rotork"), the global flow control and instrumentation group, today issues the following trading update covering the four months to 1 November 2020.

Trading update

Order intake in the third quarter showed sequential improvement, whilst remaining lower year-on-year on an OCC1 basis, with the decline slightly less than the 15.6% experienced in the first half. The majority of Rotork's activity is driven by customers' operational rather than capital expenditure and they continue to spend on automation and environmental projects as well as maintenance and refurbishment. Large project activity has remained subdued.

During the third quarter Group revenues were at 97% of the 2019 level on an OCC basis, an improvement on the first-half's 9.6% year-on-year decline. The third quarter performance largely reflected reduced activity at Rotork Site Services.

Oil & Gas sales declined more than the Group, with revenue higher year-on-year in the quarter in EMEA and Asia Pacific, but lower in the Americas. Water & Power sales grew, continuing the encouraging performance seen earlier in the year. Trading conditions remained mixed at CPI, however the Asia Pacific region returned to year-on-year growth. Overall, CPI revenue was down less than in the first half (when CPI sales were 16.8% lower).

Third quarter adjusted operating profit margins benefited from continued execution of the Growth Acceleration Programme and other management actions and we now anticipate full-year margin progress year-on-year, absent any further Covid-19 related disruption to operations.

Our Growth Acceleration Programme is on track. Our innovation and new product development initiatives are progressing well and the second half features several important launches. Our factory footprint optimisation work continues, and we recently formally opened our expanded Rochester, New York, facility. The regional back office simplification initiative is well under way.

Rotork remains highly cash generative with a strong balance sheet. Net cash at 1 November 2020 was £146.8m (£106.1m at 31 December 2019 including £10.7m of lease liabilities) after paying an interim dividend on 25 September 2020 of £34.0m in lieu of the deferred 2019 final dividend.

Covid-19 update

Our priority is the health and safety of our colleagues and their families, our customers, and suppliers. We continue to take decisive actions to manage the Covid-19 situation.

All our production facilities are currently open, albeit in a small number of cases operating at below normal output levels. Whilst every effort is being made to keep our facilities open, we will not hesitate to close them if required or if we believe there is any risk to our colleagues or their families.

Outlook

The Group's performance in the first ten months has demonstrated the improved resilience of the business. Although there remains uncertainty on the continuing impact of the Covid-19 pandemic, and risks of temporary factory closures and logistics issues, we expect 2020 adjusted operating profit to be at, or slightly above, the top end of the range of current market expectations2.

Rotork will publish 2020 full-year results on Tuesday 2 March 2021.

¹ OCC is organic constant currency results excluding discontinued businesses and restated at 2019 exchange rates

2 The current range of market expectations (company compiled) for 2020 adjusted operating profit is £124m-136m

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

About Rotork

Rotork is a market-leading global provider of mission-critical flow control and instrumentation solutions for oil & gas, water and wastewater, power, chemical process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,500 people, has manufacturing facilities in more than 20 locations and serves 173 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETLALSFII
Date   Source Headline
7th May 20246:07 pmRNSTransaction in Own Shares
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20245:53 pmRNSTransaction in Own Shares
1st May 20246:09 pmRNSTransaction in Own Shares
1st May 202412:45 pmRNSTotal Voting Rights
1st May 20249:00 amRNSBoard Committee Composition
30th Apr 20246:07 pmRNSTransaction in Own Shares
30th Apr 20243:20 pmRNSResult of AGM
30th Apr 20247:00 amRNSTrading Update
29th Apr 20246:05 pmRNSTransaction in Own Shares
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20245:47 pmRNSTransaction in Own Shares
24th Apr 20246:20 pmRNSTransaction in Own Shares
23rd Apr 20246:03 pmRNSTransaction in Own Shares
23rd Apr 202411:00 amRNSHolding(s) in Company
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:37 pmRNSTransaction in Own Shares
18th Apr 20246:09 pmRNSTransaction in Own Shares
18th Apr 20244:18 pmRNSDirector/PDMR Shareholding
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:13 pmRNSTransaction in Own Shares
15th Apr 20246:00 pmRNSTransaction in Own Shares
12th Apr 20245:53 pmRNSTransaction in Own Shares
12th Apr 20242:00 pmRNSDirector/PDMR Shareholding
11th Apr 20245:39 pmRNSTransaction in Own Shares
11th Apr 20244:59 pmRNSDirector/PDMR Shareholding
10th Apr 20246:04 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
9th Apr 20243:30 pmRNSDirector/PDMR Shareholding
8th Apr 20246:04 pmRNSTransaction in Own Shares
4th Apr 20246:07 pmRNSTransaction in Own Shares
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
2nd Apr 20244:15 pmRNSTotal Voting Rights
2nd Apr 20243:00 pmRNSDirector/PDMR Shareholding
28th Mar 20245:46 pmRNSTransaction in Own Shares
27th Mar 20246:09 pmRNSTransaction in Own Shares
26th Mar 20245:55 pmRNSTransaction in Own Shares
26th Mar 20245:28 pmRNSDirector/PDMR Shareholding
26th Mar 20242:18 pmRNS2023 Annual Report and Notice of 2024 AGM
25th Mar 20245:35 pmRNSTransaction in Own Shares
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
22nd Mar 20245:51 pmRNSTransaction in Own Shares
21st Mar 20246:17 pmRNSTransaction in Own Shares
21st Mar 20247:00 amRNSShare Buy-Back Programme
19th Mar 202410:30 amRNSHolding(s) in Company
12th Mar 20244:00 pmRNSDirector/PDMR Shareholding
11th Mar 20243:29 pmRNSDirector/PDMR Shareholding
5th Mar 20247:01 amRNSShare buy-back programme
5th Mar 20247:00 amRNS2023 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.